EptivA Therapeutics
EptivA Therapeutics is focused on developing pain treatments through a research and development platform that aims to create safer and more effective options.
- Pain Landscape®
- Pain Diseasome®
- Personalized Analgesics®
Locations
Digital Popularity
Social Media
Competitors
Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.
Company Details
EptivA Therapeutics is operated by Eptiva Therapeutics Ltd and is a Active company incorporated on 21 October 2020 with the registered office located in Oxford, Oxfordshire. Eptiva Therapeutics Ltd was registered 4 years ago.
Status
Active
Size
Micro
Directors
2
Age
4 years old
Employees
2
Turnover
Unreported
Total Assets
£127.57K
Cash in Bank
Unreported
Total Liabilities
-£314.55K